HS-CRP (High-Sensitivity C-Reactive Protein)

Immature Granulocytes

Neutrophils (Absolute)

Fibrinogen

BUN (Blood Urea Nitrogen)

HDL Cholesterol

BUN/Creatinine Ratio

Serum Cortisol

GGT (Gamma-Glutamyl Transferase)

Sed Rate (Erythrocyte Sedimentation Rate)

Hemoglobin A1C

Monocytes (Absolute)

Apolipoprotein A1

RBC (Red Blood Cell Count)

VLDL Cholesterol (calculated)

Glucose

Chloride

Apolipoprotein B

Insulin

RBC Magnesium

Total Cholesterol

LDL Particle Size

Fasting Insulin

UIBC (Unsaturated Iron Binding Capacity)

LDL Particle Number

Ferritin

ANA (Antinuclear Antibody)

Hematocrit

TSH (Thyroid Stimulating Hormone)

SHBG (Sex Hormone Binding Globulin)

Alkaline Phosphatase (ALP)

IL-6 (Interleukin-6)

RDW (Red Cell Distribution Width)

Serum Iron

LDL Cholesterol (calculated)

DHA (Docosahexaenoic Acid)

Lipoprotein(a) [Lp(a)]

Vitamin A (Retinol)

Free T3 (Triiodothyronine)

Potassium

Apolipoprotein A1 is a biomarker used in longevity research to assess cardiovascular health and predict risk of age-related diseases.

Apolipoprotein A1

Apolipoprotein A1 is a critical biomarker used in assessing the risk of cardiovascular diseases and overall longevity. It is a major component of high-density lipoprotein (HDL) particles and plays a central role in the reverse cholesterol transport pathway. Higher levels of Apolipoprotein A1 are associated with a reduced risk of developing heart diseases and are considered a favorable biomarker for longevity. Studies have shown that individuals with higher Apolipoprotein A1 levels tend to live longer and have better cardiovascular health. Thus, monitoring Apolipoprotein A1 levels can provide valuable insights into an individual’s potential for living a longer and healthier life.

Biomarker Explained

Apolipoprotein A1 is a crucial biomarker used in assessing an individual’s potential for longevity. This biomarker is a major component of high-density lipoprotein (HDL) particles and plays a central role in the reverse cholesterol transport pathway. Higher levels of Apolipoprotein A1 are associated with a reduced risk of developing heart diseases, making it a favorable biomarker for longevity. Studies have demonstrated that individuals with higher Apolipoprotein A1 levels tend to live longer and have better cardiovascular health. Therefore, monitoring Apolipoprotein A1 levels can provide valuable insights into an individual’s potential for living a longer and healthier life. Assessing the levels of Apolipoprotein A1 in an individual’s blood can help predict their risk of cardiovascular diseases and overall longevity. It is essential to consider this biomarker in combination with other relevant factors to gain a comprehensive understanding of an individual’s potential for longevity.

Keywords:

Apolipoprotein A1, longevity, biomarker, high-density lipoprotein (HDL), reverse cholesterol transport, cardiovascular health, potential for living longer

Complete Patient Intake Form

Continue Browsing Our Offers